American Journal of Kidney Diseases

Papers
(The H4-Index of American Journal of Kidney Diseases is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease395
US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States381
COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider185
Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury182
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States155
US Renal Data System 2021 Annual Data Report: Epidemiology of Kidney Disease in the United States149
Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria142
Ciliopathies and the Kidney: A Review137
ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine136
Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics129
IgA Nephropathy: Core Curriculum 2021129
Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine113
Measurement and Estimation of GFR for Use in Clinical Practice: Core Curriculum 2021110
SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis110
Membranous Nephropathy: Core Curriculum 2021101
Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients99
CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden98
Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis94
De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?93
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation91
Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report From the NKF-ASN Task Force88
Plant-Based Diets for Kidney Disease: A Guide for Clinicians86
US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States84
Osteoporosis and Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Back to Basics82
The Promise of Tubule Biomarkers in Kidney Disease: A Review81
Neutrophil Gelatinase-Associated Lipocalin Measured on Clinical Laboratory Platforms for the Prediction of Acute Kidney Injury and the Associated Need for Dialysis Therapy: A Systematic Review and Met81
Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study81
Alport Syndrome: Achieving Early Diagnosis and Treatment78
Peritoneal Dialysis Use and Practice Patterns: An International Survey Study74
Telehealth for Home Dialysis in COVID-19 and Beyond: A Perspective From the American Society of Nephrology COVID-19 Home Dialysis Subcommittee68
Burden of Kidney Disease, Health-Related Quality of Life, and Employment Among Patients Receiving Peritoneal Dialysis and In-Center Hemodialysis: Findings From the DOPPS Program67
The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort Study66
Special Considerations for Paxlovid Treatment Among Transplant Recipients With SARS-CoV-2 Infection66
Patient and Caregiver Priorities for Outcomes in CKD: A Multinational Nominal Group Technique Study62
The Difference Between Cystatin C– and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)61
Clinical Application of Kidney Biomarkers in Cirrhosis60
COVID-19 Outbreak in an Urban Hemodialysis Unit60
Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study59
Pathophysiology and Management of Hyperoxaluria and Oxalate Nephropathy: A Review56
Coffee and Caffeine Consumption and Risk of Kidney Stones: A Mendelian Randomization Study55
Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study54
Strategies to Treat Obesity in Patients With CKD53
Kidney Biopsy Findings in Patients With COVID-19, Kidney Injury, and Proteinuria53
Mobile Health (mHealth) Technology: Assessment of Availability, Acceptability, and Use in CKD53
Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy52
Successful Treatment of Patients With Refractory PLA2R-Associated Membranous Nephropathy With Obinutuzumab: A Report of 3 Cases52
A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population51
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study51
An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine48
0.037996053695679